TY - JOUR
T1 - Functions for the cardiomyokine, MANF, in cardioprotection, hypertrophy and heart failure
AU - Glembotski, Christopher C.
N1 - Funding Information:
Research in the author's laboratory is supported by the National Institutes of Health ( PO1 HL085577 , RO1 HL75573 , RO1 HL104535 , and RO3 EB011698 ), the California Institute for Regenerative Medicine ( TB1-01193 ), the Rees-Stealy Research Foundation , the San Diego Chapter of the Achievement Rewards for College Scientists (ARCS) Foundation , and the American Heart Association ( 10PRE3410005 ).
PY - 2011/10
Y1 - 2011/10
N2 - We define cardiomyokines as heart-derived secreted proteins that affect cardiovascular function via autocrine, paracrine and/or endocrine mechanisms. The subject of this review is the cardiomyokine, mesencephalic astrocyte-derived neurotrophic factor (MANF). The expression of MANF is increased in the ischemic heart, in part, through activation of ER stress, a condition that drastically impairs the expression and secretion of most cardiomyokines. This novel function of MANF suggests that it may have important roles in the ER stressed, ischemic heart. Consistent with this are recent findings showing that MANF protects against ischemic damage, and that it is anti-hypertrophic. Accordingly, in light of its function as a potentially secreted cardiomyokine, MANF has translational potential as a novel therapy for ischemic heart disease. This article is part of a special issue entitled "Key Signaling Molecules in Hypertrophy and Heart Failure".
AB - We define cardiomyokines as heart-derived secreted proteins that affect cardiovascular function via autocrine, paracrine and/or endocrine mechanisms. The subject of this review is the cardiomyokine, mesencephalic astrocyte-derived neurotrophic factor (MANF). The expression of MANF is increased in the ischemic heart, in part, through activation of ER stress, a condition that drastically impairs the expression and secretion of most cardiomyokines. This novel function of MANF suggests that it may have important roles in the ER stressed, ischemic heart. Consistent with this are recent findings showing that MANF protects against ischemic damage, and that it is anti-hypertrophic. Accordingly, in light of its function as a potentially secreted cardiomyokine, MANF has translational potential as a novel therapy for ischemic heart disease. This article is part of a special issue entitled "Key Signaling Molecules in Hypertrophy and Heart Failure".
KW - Cardiomyokine
KW - Cardioprotection
KW - ER stress
KW - Hypertrophy
KW - MANF
UR - http://www.scopus.com/inward/record.url?scp=80052808518&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80052808518&partnerID=8YFLogxK
U2 - 10.1016/j.yjmcc.2010.10.008
DO - 10.1016/j.yjmcc.2010.10.008
M3 - Review article
C2 - 20970425
AN - SCOPUS:80052808518
SN - 0022-2828
VL - 51
SP - 512
EP - 517
JO - Journal of Molecular and Cellular Cardiology
JF - Journal of Molecular and Cellular Cardiology
IS - 4
ER -